Hot Features
Premium
No photos found.
Yes, very quiet, no sign of Z1CO who was very vocal in run up to last earnings announcement in Sept.BOD Expecting to be in profit before EBITDA,
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
This user has no comment yet.
| No profile data added yet. |
No photos found.
Yes, very quiet, no sign of Z1CO who was very vocal in run up to last earnings announcement in Sept.BOD Expecting to be in profit before EBITDA,
JB - As per Interim Report issued on 27th September-VAL301 in vitro preclinical testing is currently on hold whilst we clarify the position around
Hi Nick - hope you’re well. You were always very upfront and transparent regarding your VAL trades when you did not have to be and copped a lot of
It all reads & bodes well. It will be interesting to see if, now that Directors are out of the Close Period, they make further share purchases. The
IMHO although the acquisition cost was not disclosed in the RNS, as ZOO did not advise of any external funding requirement eg placing, rights issue
RNS - ZOO Digital launches dubbing studios in Milan, Italy. More good newsflow.
RonPharma, It might be of interest that the Co-inventor of Cytolytix CLX001 at Kings College along with Martin Ulmschneider was Charles Chen who was
It could be either, neither, or both of Liontrust or Cannacord. We will not know until next RNS re Holding.
Thanks seagreen, that made me titter, both the positive ZOO news and that brightening up a grey wet morning.
Interesting - two large Buy trades of 1M shares each went through today, a hefty £30k each one..
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
